Ligand Pharmaceuticals Incorporated LGNXZ Company

New Post Public Reply Private Reply Replies (0) Message Board

Sep 7, 2013 at 4:12 PM

Ligand Pharmaceuticals Incorporated LGNXZ Company Overview

Stock Message Board http://investorshangout.com/search?q=LGNXZ&am...mp;yt1=Go!

Ligand Pharmaceuticals Incorporated LGNXZ Current Price and Quotes
Last Price 0.066
Previous Close 0.066 Open 0.066
Daily Range 0.066 - 0.066 52wk Range 0.125 - 0.005
Volume 2,000 Dividend N/A
Average Vol (3m) 6,999 Yield N/A
Ligand Pharmaceuticals Incorporated LGNXZ
Company Information

11119 North Torrey Pines Road
Suite 200
La Jolla, CA 92037

Website: http://www.ligand.com
Phone: 858-550-7500

Ligand Pharmaceuticals Incorporated LGNXZ
Ligand discovers, develops and markets new drugs for critical unmet medical needs in the areas of cancer, pain, skin diseases, hormone-related diseases, osteoporosis, metabolic disorders, cardiovascular and inflammatory diseases. Ligand's proprietary drug discovery and development programs are based on its leadership position in gene transcription technology related to intracellular receptors.

Ligand Pharmaceuticals Incorporated LGNXZ
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Not Available
Latest Report Jun 30, 2013 10-Q
CIK 0000886163
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data

SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. 1987
Employees 550 a/o Dec 31, 2004
Company Officers/Contacts

David E. Robinson President, CEO
Paul V. Maier CFO
Matthew W. Foehr EVP, COO
Charles S. Berkman Vice President, Secretary, General Counsel
Erika Luib IR
Company Directors

David E. Robinson Chairman
John LaMattina
Sunil Patel
Service Providers

Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available

Ligand Pharmaceuticals Incorporated LGNXZ
LGNXZ Security Details Other Company Securities

Share Structure

Market Value1 Not Available
Shares Outstanding Not Available
Float Not Available
Authorized Shares Not Available
Par Value No Par Value
Shareholders

Shareholders of Record Not Available
Short Selling Data

Short Interest 0 (-100%)
Jul 15, 2011
Significant Failures to Deliver No
Transfer Agent(s)

Ligand Pharmaceuticals Incorporated LGNXZ Recent News

Sept 5, 2013 OTC Signal Daily Stock Watch - Ligand Pharmaceuticals Incorporated (NASDAQ: LGND)
Aug 14, 2013 Ligand Enters Global License Agreement with CURx Pharmaceuticals, Inc. for Captisol-Enabled(TM) Topiramate Injection
Aug 1, 2013 Ligand Reports Second Quarter Financial Results
Jul 29, 2013 New License Agreements and Financial Results Release - Research Report on Elan, Waters, InterMune, Spectranetics, and Ligand
Jul 26, 2013 Ligand Partner GlaxoSmithKline Receives Positive CHMP Opinion for REVOLADE(TM) in Thrombocytopenia Associated with Chronic Hepatitis C Infection
Jul 26, 2013 Ligand Receives Orphan Designation for Captisol-Enabled(TM) Topiramate Injection
Jul 24, 2013 Ligand Signs License Agreement with Ethicor for Oral Lasofoxifene
Jul 22, 2013 Ligand Signs Global License Agreement with Azure for Lasofoxifene
Jul 17, 2013 Ligand to Report Second Quarter Results on August 1st
Jun 24, 2013 Ligand Announces Positive Preclinical Data for Glucagon Program in Model of Type 1 Diabetes

1
2
next >

Ligand Pharmaceuticals Incorporated LGNXZ Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009
Total Revenue 31,388 30,037 23,538 38,940
Cost of Revenue 3,601 4,909 - -
Gross Profit 27,787 25,128 23,538 38,940
Operating Expenses

Research and Development 10,790 10,291 22,067 39,870
Sales, General and Admin. 16,108 13,275 11,127 (6,640)
Non-Recurring Items 315 2,260 19,648 15,677
Other - - - -
Operating Income 574 (698) (29,304) (9,967)
Income From Continuing Operations

Add'l Income/Expense Items (1,134) (383) 13,519 365
Earnings Before Interest and Tax (3,865) (3,558) (15,403) (9,602)
Interest Expense - - - 270
Earnings Before Tax (3,865) (3,558) (15,403) (9,872)
Income Tax (1,191) (13,270) (2,617) (1,535)
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (2,674) 9,712 (12,786) (8,337)
Non Recurring Events

Discontinued Operations 2,147 3 2,413 6,389
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (527) 9,715 (10,373) (1,948)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (527) 9,715 (10,373) (1,948)

LGNXZ Ligand Pharmaceuticals Incorporated Research DD Guide

LGNXZ Ligand Pharmaceuticals Incorporated Stock Message Board http://investorshangout.com/search?q=LGNXZ&am...mp;yt0=Go!
LGNXZ Ligand Pharmaceuticals Incorporated Stock Quote http://www.otcmarkets.com/stock/LGNXZ/quote
LGNXZ Ligand Pharmaceuticals Incorporated Stock Chart http://www.otcmarkets.com/stock/LGNXZ/chart
LGNXZ Ligand Pharmaceuticals Incorporated Company Info http://www.otcmarkets.com/stock/LGNXZ/company-info
LGNXZ Ligand Pharmaceuticals Incorporated Recent News http://www.otcmarkets.com/stock/LGNXZ/news
LGNXZ Ligand Pharmaceuticals Incorporated Financials http://www.otcmarkets.com/stock/LGNXZ/financials
LGNXZ Ligand Pharmaceuticals Incorporated Filings and Disclosure http://www.otcmarkets.com/stock/LGNXZ/filings
LGNXZ Ligand Pharmaceuticals Incorporated Short Sales http://www.otcmarkets.com/stock/LGNXZ/short-sales
LGNXZ Ligand Pharmaceuticals Incorporated Insider Disclosure http://www.otcmarkets.com/stock/LGNXZ/insider-transactions
LGNXZ Ligand Pharmaceuticals Incorporated Research Reports http://www.otcmarkets.com/stock/LGNXZ/research
LGNXZ Ligand Pharmaceuticals Incorporated Summary http://finance.yahoo.com/q?s=LGNXZ
LGNXZ Ligand Pharmaceuticals Incorporated Historical Prices http://finance.yahoo.com/q/hp?s=LGNXZ+Historical+Prices
LGNXZ Ligand Pharmaceuticals Incorporated Interactive Chart http://finance.yahoo.com/echarts?s=LGNXZ
LGNXZ Ligand Pharmaceuticals Incorporated Basic Chart http://finance.yahoo.com/q/bc?s=LGNXZ+Basic+Chart
LGNXZ Ligand Pharmaceuticals Incorporated Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=LGNXZ+Basic+Tech.+Analysis
LGNXZ Ligand Pharmaceuticals Incorporated Headlines http://finance.yahoo.com/q/h?s=LGNXZ+Headlines
LGNXZ Ligand Pharmaceuticals Incorporated Press Releases http://finance.yahoo.com/q/p?s=LGNXZ+Press+Releases
LGNXZ Ligand Pharmaceuticals Incorporated Company Profile http://finance.yahoo.com/q/pr?s=LGNXZ+Profile
LGNXZ Ligand Pharmaceuticals Incorporated Key Statistics http://finance.yahoo.com/q/ks?s=LGNXZ+Key+Statistics
LGNXZ Ligand Pharmaceuticals Incorporated Industry http://finance.yahoo.com/q/in?s=LGNXZ+Industry
LGNXZ Ligand Pharmaceuticals Incorporated Major Holders http://finance.yahoo.com/q/mh?s=LGNXZ+Major+Holders
LGNXZ Ligand Pharmaceuticals Incorporated Insider Transactions http://finance.yahoo.com/q/it?s=LGNXZ+Insider+Transactions
LGNXZ Ligand Pharmaceuticals Incorporated Insider Roster http://finance.yahoo.com/q/ir?s=LGNXZ+Insider+Roster
LGNXZ Ligand Pharmaceuticals Incorporated Income Statement http://finance.yahoo.com/q/is?s=LGNXZ
LGNXZ Ligand Pharmaceuticals Incorporated Balance Sheet http://finance.yahoo.com/q/bs?s=LGNXZ
LGNXZ Ligand Pharmaceuticals Incorporated Cash Flow http://finance.yahoo.com/q/cf?s=LGNXZ+Cash+Flow&annual
LGNXZ Ligand Pharmaceuticals Incorporated Nasdaq http://www.nasdaq.com/symbol/LGNXZ
LGNXZ Ligand Pharmaceuticals Incorporated Market Watch http://www.marketwatch.com/investing/stock/LGNXZ
LGNXZ Ligand Pharmaceuticals Incorporated Bloomberg http://www.bloomberg.com/quote/LGNXZ:US
LGNXZ Ligand Pharmaceuticals Incorporated Morningstar http://quotes.morningstar.com/stock/s?t=LGNXZ
LGNXZ Ligand Pharmaceuticals Incorporated Bussinessweek http://investing.businessweek.com/research/st...cker=LGNXZ
LGNXZ Ligand Pharmaceuticals Incorporated Barchart http://www.barchart.com/quotes/stocks/LGNXZ
LGNXZ Ligand Pharmaceuticals Incorporated OTC Short Report http://otcshortreport.com/index.php?index=LGNXZ
LGNXZ Ligand Pharmaceuticals Incorporated Investopedia http://www.investopedia.com/markets/stocks/LGNXZ/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Haag-Streit Debuts Innovative Octopus 910 Perimeter at AAO

Now here's something that'll tickle your ophthalmologist's fancy—Haag-Streit USA has rolled out the Octopus 910, a slick piece of kit set to shake up visual field testing for glaucoma management. This time, they're getting in front of the competition, unveiling it at the Association for Research in Vision and Ophthalmology's 2026 shindig in New Orleans. With this new...

Zoomlion Boosts Mining Gear Amid Global Revenue Surge

An Ambitious Expansion Overhaul Alright, let's talk Zoomlion Heavy Industry Science & Technology Co., Ltd. They're not just making a splash; they're wading knee-deep into expanding their mining machinery operations and taking charge in international markets. You see, in the first half of 2026, this Chinese behemoth saw its mining machinery business skyrocket by over...

KAPSARC Drives Energy Dialogue at WPC in Riyadh

Defining Energy Horizons in Riyadh Mark those calendars, because as the global energy crowd descends on Riyadh from October 11 to 15, 2026, KAPSARC steps into the spotlight. As the National Partner at the 25th World Petroleum Congress (WPC), they're not just warming the bench—they're playing every position, shaking up the field of energy. Paving the Pathways with...

AI Revenue Missteps Shake Semiconductor Stocks

Nervous Times for Semiconductor Stocks When the semiconductor sector started October like a high-speed train, I thought we might sail through this month without hitting turbulence. But then, in trotted some shaky AI revenue numbers, and bam, the whole sector took a hit off its October highs. The semiconductor stocks, led by giants like Taiwan Semiconductor Manufacturing...

RingConn Smart Ring Gains Key FDA 510(k) Clearance

FDA Clearance: A Major Step for RingConn In a space where every tiny gadget-maker is desperately clawing for a regulatory nod, RingConn—a venture born from Shenzhen Ninenovo Technology Limited—has snagged an FDA 510(k) clearance (Clearance No. K260490) for their wearable Smart Ring that measures blood oxygen levels non-invasively. October 10, 2026, marked the day when...

Tchah Sup Kim: A Retrospective at KCCNY in 2026

A Glimpse into Tchah Sup Kim's Legacy Stumble into the world of Tchah Sup Kim (1940–2022) this fall at the Korean Cultural Center New York. Kim's posthumous retrospective, "The Key to a New World," brings together over 130 of his works alongside archival materials, offering a comprehensive dive into a mind that spent decades between New York and Korea. The exhibit,...

Kexing Biopharm Expands Global Reach at CPHI Milan

Kexing Biopharm's Showstopper Moment in Milan Call it a strategic blowout or just audacious timing—Kexing Biopharm's move at the CPHI Milan 2026 has painted a clear picture. From October 6th to 8th, Milan was the stage where Kexing rolled out its showcase, bragging about a pipeline that screams innovation and possibility. And let’s be honest, their timing couldn’t...

Retail Trading Platforms Report Record Growth in 2026

A Boom in Self-Directed Investing Times are changing, folks. More people than ever are taking finance into their own hands, wielding smartphones like fiscal swords in the name of self-directed investment. No middlemen, no fancy office, just straight-up trading from wherever you might be perched. Four major platforms now boast over 41 million funded accounts combined, each...

APsystems Unveils C&I Storage Solutions at SEF 2026

APsystems Puts the Spotlight on Advanced Storage Move over, traditional energy solutions—APsystems is stepping into the future with a bang at the Smart Energy Forum 2026 in Prague. Set your sights on the latest advancements in solar and energy storage solutions as the company unveils its comprehensive offerings. If you’re hanging around the PVA EXPO PRAHA on October...

CenterPoint Deploys Crews for Hurricane Aid Relief

CenterPoint’s Commitment Amidst Crisis Now, when a hurricane slams into the coast, it’s go time for everyone in the game. CenterPoint Energy, never one to sit on the sidelines, is showing up with a hefty squad to help fix the mess left by Hurricane Isaias. A robust 355-strong team is heading out to assist with power restoration down there in Florida. This isn’t just...